Search
forResearch 10 of 1000+
- Application of 2-Chloro-7-Nitrobenzo-2-Oxa-1, 3-Diazol (NBDCL) for Spectrophotometric Determination of Finasteride in Pharmaceutical Formulation
- Pharmaceutical, Pharmacological and Pharmachemistrical Prospectus of ayurvedic Formulations for Alopecia: A Comprehensive Evidence Based Systematic Review
- Pharmaceutical, Pharmacological and Pharmachemistrical Prospectus of ayurvedic Formulations for Alopecia: A Comprehensive Evidence Based Systematic Review
- Analytical chemistry studying historical pharmaceuticals and health care formulations
- Integrating herbal components into pharmaceutical formulations for hair woes
- Botanical Synergies for Hair Health: A Review of Saw Palmetto and Urtica dioica in Non-Pharmaceutical Formulations
- Electrochemical Determination of Minoxidil in Different Pharmaceutical Formulations by Flow Injection Analysis
- Second derivative spectrophotometric method for simultaneous determination of tamsulosin and finasteride in pharmaceutical formulations
- Sensitive Bromatometric Determination Of Finasteride In Pharmaceuticals Based On Complex-Formation Reactions
- Development and Validation of Spectrophotometric Method for Determination of Finasteride in Pharmaceutical Formulation Using 1,2-Naphthoquine-4-sulfonate (NQS)
Community 10 of 50
- Pelage Pharmaceutical Raises 120 million to continue PP405 Research. Link inside.
- Kintor Pharmaceutical’s KX-826 Shows Promising Results in Hair Loss Study
- Cosmo Pharmaceutical (Breezula) fiscal results. Top Line Six month results expected early in the second half of this year.
- JW Pharmaceutical shows superiority of 'JW0061' in hair growth over existing treatments in US
- Pelage Pharmaceuticals Phase 3 Trials for PP405 Start in September 2026
- Pelage Pharmaceuticals posted a tweet about PP405.
- Pelage Pharmaceuticals with an absolute stunner of a molecule
- Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 28th march
- Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026
- Pelage Pharmaceuticals' PP405 listed on Time Magazine's List of Best Inventions of 2025
Learn
— no results
Try a deeper search in learn →